Webinar | October 12, 2023

Trailblazer Webinar: Overcoming Financial Toxicity In Oncology Clinical Trials

Source: Greenphire

Participation in clinical trials among adult cancer patients remains low, with fewer than 5% taking part. According to reports, this statistic is largely attributed to the formidable financial challenges and costs associated with oncology clinical trials, which often deter eligible candidates.

But, Greenphire has extended an invitation to be a part of the change. In this Trailblazer Webinar, viewers can watch as the following speakers shed light on innovative strategies leading the way toward a more favorable patient experience and enhanced study results:

  • Jim Murphy, CEO, Greenphire
  • Mark Fleury, Principal, Policy Development, Emerging Science, American Cancer Society Cancer Action Network
  • Tim Dorsey, Team Lead, Product Training, Greenphire
  • Elizabeth Barksdale, Senior Director of Regulatory Affairs and Scientific Policy, LUNGevity

Discover the historical struggles of oncology research due to financial toxicity, explore industry initiatives aimed at eliminating these barriers, and learn about ongoing advocacy efforts in Washington, D.C., focused on reducing the tax implications of patient stipends.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader